Agile therapeutics announces changes to its board of directors

Princeton, n.j., april 22, 2020 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx), a forward-thinking women’s healthcare company, today announced that the company has nominated sharon barbari for election as a class iii director to replace abhijeet lele, a member of the company’s board of directors and the board’s lead independent director, who will not stand for re-election and cease to be a director on june 9, 2020, the date of the company’s annual meeting of stockholders. in addition, william mckee has informed the company that he will retire from the company’s board of directors effective june 9, 2020. the company plans to appoint sandra carson, m.d., facog as a class ii director to replace mr. mckee when he retires.
AGRX Ratings Summary
AGRX Quant Ranking